Biotech Growth Investors & VC Firms
708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
Astorg
ParisGrowth–Late Stage
51 people
Manta Ray Ventures
LondonPre-Seed–Growth
8 people
Taiwania Capital
TaipeiSeed–Growth
49 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Nexxus Capital
Mexico CityGrowth$15M – $50M
50 people
Eurazeo
ParisSeed–Late Stage
35 people
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
Johnson & Johnson Innovation – JJDC
New BrunswickSeed–Growth
42 people
High Tech Gruenderfonds
BonnPre-Seed–Growth$880K – $33M
21 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
44 people
Korys
HalleGrowth$5.4M
40 people
Olive Tree Capital
BostonSeed–Growth
6 people
redalpine
ZugSeed–Growth$108K – $2.2M
28 people
LIFTT
TorinoPre-Seed–Growth
36 people
Siddhi Capital
MeridianGrowth
29 people
ATEL Ventures
San FranciscoSeed–Late Stage
15 people
NV NOM
GroningenSeed–Growth
27 people
Ampersand
BostonGrowth
36 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
38 people
S32
Palo AltoSeries A–Late Stage
30 people
Hitachi Ventures
MunichSeed–Growth
32 people
Shunwei Capital
BeijingSeed–Growth
25 people
Supernova Invest
ParisSeed–Growth
34 people
Related lists
Growth Investors & VC Firms (4264)Biotech Investors & VC Firms (2475)Growth Investors & VC Firms in North America (2122)Biotech Seed Investors & VC Firms (2020)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Biotech Series A Investors & VC Firms (1626)Biotech Investors & VC Firms in North America (1594)Biotech Investors & VC Firms in United States (1445)Growth Investors & VC Firms in Global (1378)
Data sourced from public filings and firms' own websites — see our methodology.













































































































